<DOC>
	<DOCNO>NCT00218413</DOCNO>
	<brief_summary>Nicotine highly addictive many individual unable quit smoke even treatment . The purpose study determine effectiveness various dos NicVAX treat nicotine dependent individual .</brief_summary>
	<brief_title>Safety Effectiveness NicVAX Treating Nicotine Dependent Individuals</brief_title>
	<detailed_description>Tobacco use single lead preventable cause death United States . Nicotine alkaloid derive tobacco plant responsible psychoactive addictive effect smoke . Immunotherapy may useful prevent treat nicotine dependent individual . NicVAX nicotine vaccine , type immunotherapy may effective smoking cessation prevent relapse nicotine . The purpose study evaluate safety efficacy various dosing level dose frequency NicVAX treat nicotine dependent individual .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Current smoker Good general health , include mental health Alveolar carbon monoxide level great equal 10 ppm Prior exposure NicVAX Known allergy component NicVAX Use smoke cessation aide Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Addiction</keyword>
</DOC>